etoposide has been researched along with casein kinase ii in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corbett, AH; DeVore, RF; Osheroff, N | 1 |
| Chresta, CM; Francis, GE; Hall, BF | 1 |
| Alghisi, GC; Gasser, SM; Roberts, E; Vassetzky, YS | 1 |
| Ahmed, K; Davis, AT; Green, JE; Guo, C; Wang, H; Yu, S | 1 |
| Penzo, D; Pinna, LA; Ruzzene, M | 1 |
| Beneytout, JL; Bertrand, J; Ghezali, L; Leger, DY; Liagre, B | 1 |
6 other study(ies) available for etoposide and casein kinase ii
| Article | Year |
|---|---|
Phosphorylation of topoisomerase II by casein kinase II and protein kinase C: effects on enzyme-mediated DNA cleavage/religation and sensitivity to the antineoplastic drugs etoposide and 4'-(9-acridinylamino)methane-sulfon-m-anisidide.
Topics: Amsacrine; Casein Kinase II; DNA; DNA Topoisomerases, Type II; Etoposide; Nucleic Acid Denaturation; Nucleic Acid Renaturation; Phosphorylation; Protein Kinase C; Protein Serine-Threonine Kinases | 1992 |
Retinoic acid and phorbol ester induced hyperphosphorylation of topoisomerase II-alpha is an early event in HL-60 human leukaemia cell differentiation: effect on topoisomerase activity and etoposide sensitivity.
Topics: Antigens, Neoplasm; Casein Kinase II; Cell Differentiation; Cell Nucleus; Cell Survival; DNA Topoisomerases, Type II; DNA-Binding Proteins; Enzyme Activation; Etoposide; Humans; In Vitro Techniques; Isoenzymes; Leukemia, Myeloid; Peptide Mapping; Phorbol Esters; Phosphorylation; Protein Serine-Threonine Kinases; Time Factors; Tretinoin; Tumor Cells, Cultured | 1995 |
Ectopic expression of inactive forms of yeast DNA topoisomerase II confers resistance to the anti-tumour drug, etoposide.
Topics: Amino Acid Sequence; Binding Sites; Casein Kinase II; Culture Media; DNA Topoisomerases, Type II; Drug Resistance; Etoposide; Gene Expression; Genetic Complementation Test; Molecular Sequence Data; Phosphoproteins; Protein Serine-Threonine Kinases; Saccharomyces cerevisiae; Sequence Deletion; Structure-Activity Relationship | 1996 |
A potential role of nuclear matrix-associated protein kinase CK2 in protection against drug-induced apoptosis in cancer cells.
Topics: Adenocarcinoma; Animals; Apoptosis; Casein Kinase II; Catalytic Domain; Cell Compartmentation; Cytoprotection; Cytosol; Diethylstilbestrol; DNA, Neoplasm; Etoposide; Female; Humans; Male; Mammary Neoplasms, Animal; Mice; Nuclear Matrix; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Protein Transport; Recombinant Proteins; Subcellular Fractions | 2001 |
Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Blood Proteins; Casein Kinase II; Caspase 3; Caspases; Cell Death; Cell Survival; Cytochrome c Group; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; Humans; Jurkat Cells; Phosphorylation; Poly(ADP-ribose) Polymerases; Precipitin Tests; Protein Binding; Protein Serine-Threonine Kinases; Serine; Threonine; Time Factors; Triazoles; Tyrosine | 2002 |
Cyclooxygenase-2 positively regulates Akt signalling and enhances survival of erythroleukemia cells exposed to anticancer agents.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Casein Kinase II; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Etoposide; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Erythroblastic, Acute; Oxides; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; RNA, Small Interfering; Signal Transduction; Staurosporine | 2013 |